InvestorsHub Logo
Followers 21
Posts 3582
Boards Moderated 0
Alias Born 12/18/2019

Re: Roman516 post# 611660

Friday, 07/21/2023 8:42:13 PM

Friday, July 21, 2023 8:42:13 PM

Post# of 715997
The bias is in the NWBO trial redesign -- the ECA that was done after the trial was virtually completed, tossing out the failed primary endpoint results, etc. Clearly issues the FDA will find at issue.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News